Comparison
hCG vs Kisspeptin-10
Both are reproductive & HPTA, so the meaningful differences are in kinetics, evidence and regulatory status.
On published evidence alone, hCG is the better documented of the two (regulator approved). That is a statement about the state of the literature, not a recommendation.
| hCG | Kisspeptin-10 | |
|---|---|---|
| Class | Reproductive & HPTA | Reproductive & HPTA |
| Evidence | Regulator approved | Clinical trials |
| Human trials | ~60 | ~25 |
| Half-life | ~24-36 hours | ~4 minutes |
| Reported range | 250 mcg - 1.5 mg | 10-100 mcg |
| Frequency | 2-3x weekly (dosed in international units) | Research protocols vary widely |
| Routes | Subcutaneous, Intramuscular | Subcutaneous, Intramuscular |
| FDA approved | Yes | No |
| Research use only | No | Yes |
| Banned in sport | Yes | No |
| Studied for | Preservation of fertility and testicular volume on TRT, Hypogonadotropic hypogonadism, Ovulation induction | Reproductive axis research, Fertility research, Sexual desire research |
| Reported side effects | Gynaecomastia, Water retention, Acne, Mood changes, Injection-site reactions | Flushing, Injection-site reactions, Headache |
hCG
Human chorionic gonadotropin is a glycoprotein hormone, not a simple peptide, structurally similar to luteinising hormone and acting at the same LH/CG receptor. In men it stimulates Leydig cells directly to produce testosterone and maintains testicular volume and intratesticular testosterone during exogenous androgen therapy. Because it acts downstream of the pituitary it works even when the HPTA is fully suppressed, which is the practical difference from gonadorelin.
Kisspeptin-10
Kisspeptin-10 is the shortest active fragment of kisspeptin, the peptide encoded by KISS1 that acts at the KISS1R receptor on hypothalamic GnRH neurons. It sits one level above GnRH in the reproductive hierarchy and is the principal gatekeeper of puberty and fertility, integrating metabolic and hormonal signals. Because it stimulates endogenous pulsatile GnRH rather than replacing it, research interest centres on inducing more physiological LH release than direct GnRH dosing achieves.
hCG vs Kisspeptin-10: common questions
What is the difference between hCG and Kisspeptin-10?
Both are reproductive & HPTA. hCG: A placental glycoprotein hormone that mimics LH directly at the testis, the long-standing standard for preserving fertility on TRT. Kisspeptin-10: The upstream trigger for GnRH release, and the most physiologically natural way to stimulate the reproductive axis.
Which has stronger evidence, hCG or Kisspeptin-10?
hCG has the stronger evidence base (regulator approved, about 60 human studies) compared with Kisspeptin-10 (clinical trials).
Are hCG and Kisspeptin-10 FDA approved?
Only hCG is FDA approved (Prepubertal cryptorchidism; Hypogonadotropic hypogonadism in males; Ovulation induction). Kisspeptin-10 is not approved for any indication.
References
Regulatory and primary sources
- PubChem compound record (CID 4369448) ↗ · structure, identifiers, synonyms
- DailyMed: FDA-approved labeling for hCG ↗ · indications, dosing, warnings as approved
- FDA Drugs@FDA database ↗ · approval history
- WADA Prohibited List ↗ · current year
- CAS Registry Number 9002-61-3 ↗ · chemical identity
- PubChem compound record (CID 25240297) ↗ · structure, identifiers, synonyms
- FDA: Unapproved drugs and "research use only" products ↗ · regulatory status of non-approved products
- CAS Registry Number 374675-21-5 ↗ · chemical identity
Published literature
- Micropenis.Indian J Pediatr 2023.PubMed 37079255 · doi:10.1007/s12098-023-04540-w
- Testicular Germ Cell Tumors: A Review.JAMA 2025.PubMed 39899286 · doi:10.1001/jama.2024.27122
- Anabolic steroid-induced hypogonadism: diagnosis and treatment.Fertil Steril 2014.PubMed 24636400 · doi:10.1016/j.fertnstert.2014.02.002
- A Current Perspective on Delayed Puberty and Its Management.J Clin Res Pediatr Endocrinol 2024.PubMed 38683021 · doi:10.4274/jcrpe.galenos.2024.2024-2-7
- Gonadotropin resistance.Endocr Dev 2013.PubMed 23392092 · doi:10.1159/000342496
- The normal menstrual cycle in women.Anim Reprod Sci 2011.PubMed 20869180 · doi:10.1016/j.anireprosci.2010.08.030
- Anti-fertility vaccines.Vaccine 1989.PubMed 2665354 · doi:10.1016/0264-410x(89)90043-1
- Testosterone replacement therapy and spermatogenesis in reproductive age men.Nat Rev Urol 2025.PubMed 40346275 · doi:10.1038/s41585-025-01032-8
- GPR54 and kisspeptin in reproduction.Hum Reprod Update 2006.PubMed 16731583 · doi:10.1093/humupd/dml023
- KISS1 in breast cancer progression and autophagy.Cancer Metastasis Rev 2019.PubMed 31705228 · doi:10.1007/s10555-019-09814-4
- Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.Nutr Metab Cardiovasc Dis 2020.PubMed 32409274 · doi:10.1016/j.numecd.2020.02.017
- Role of Kisspeptin and NKB in Puberty in Nonhuman Primates: Sex Differences.Semin Reprod Med 2019.PubMed 31847024 · doi:10.1055/s-0039-3400253
- The role of kisspeptin and GPR54 in the hippocampus.Peptides 2009.PubMed 18765263 · doi:10.1016/j.peptides.2008.07.023
- Endocrine-metabolic effects of kisspeptin in mammals.Gen Comp Endocrinol 2026.PubMed 41581529 · doi:10.1016/j.ygcen.2026.114888
- Kisspeptins (KiSS-1): essential players in suppressing tumor metastasis.Asian Pac J Cancer Prev 2013.PubMed 24377507 · doi:10.7314/apjcp.2013.14.11.6215
- The kisspeptin (KiSS-1)/GPR54 system in cancer biology.Cancer Treat Rev 2008.PubMed 18583061 · doi:10.1016/j.ctrv.2008.05.007
Literature retrieved from PubMed on October 16, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.